Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-10-13
1994-01-04
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 548250, 548252, 548253, 548254, 5483147, A61K 31415, C07D40314, C07D40304
Patent
active
052760480
ABSTRACT:
Novel substituted 4-(1-H-pyrrol-1-yl)imidazoles are disclosed as well as methods of preparing them, pharmaceutical compositions containing them, and methods of using them. Novel intermediates useful in the preparation of the compounds of the invention are also disclosed and synthetic methods for preparing the novel intermediates. The compounds are useful as antagonists of angiotensin II and thus are useful in the control of hypertension, hyperaldosteronism, congestive heart failure, glaucoma, vascular smooth muscle proliferation associated with atherosclerosis, and with postsurgical vascular restenosis.
REFERENCES:
Hypertension, 18[Suppl. II]:II60-II64 (1991).
Japan J. Pharmacol., 52:541-552 (1990).
FASEB, 52(4):A869 (1990).
Hodges John C.
Topliss John G.
Anderson Elizabeth M.
Morris Patricia L.
Warner-Lambert & Company
LandOfFree
4-(1H-pyrrol-1-yl)imidazoles with angiotensin II antagonist acti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(1H-pyrrol-1-yl)imidazoles with angiotensin II antagonist acti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(1H-pyrrol-1-yl)imidazoles with angiotensin II antagonist acti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307519